Please login to the form below

Not currently logged in
Email:
Password:

Cell Medica

This page shows the latest Cell Medica news and features for those working in and with pharma, biotech and healthcare.

New centre aims to Catapult UK into cell and gene therapy lead

New centre aims to Catapult UK into cell and gene therapy lead

It is already working with four biotechs working in so-called ‘advanced therapies’ - Autolus, Cell Medica, AdaptImmune and Freeline. ... it can introduce the complex CAR-T cell harvesting and reinfusion process via the specialist centres.

Latest news

  • UK regenerative medicine projects get £8.5m boost

    UK regenerative medicine projects get £8.5m boost. Cell Medica, Intercytex and Lonza Biologics among the companies to benefit. ... An £8.5m package of grants will be shared by 14 projects in development by companies that include Cell Medica,

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Aelix Therapeutics appoints Dr Thomas Hecht Aelix Therapeutics appoints Dr Thomas Hecht

    He currently serves as chairman of the supervisory board at Affined, chairman of the board of directors at Cell Medica and Vaximm.

  • Cell Medica adds to senior management team Cell Medica adds to senior management team

    Cell Medica adds to senior management team. Alain Pralong and Stefanos Theoharis join. ... Meanwhile, Theoharis (pictured left) has been tasked with leading Cell Medica's pipeline development strategy and managing its strategic partnerships.

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Conferences, Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics